Loading clinical trials...
Loading clinical trials...
Data about transgender medical care, especially the gender-affirming hormone therapy (GAHT) is extremely insufficient in China. Few evidence exists in the physical and psychological effects of the hor...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Peking University Third Hospital
Collaborators
NCT07252687 · Transgender, Gender Dysphoria in Adolescents and Adults
NCT06357130 · Transgender Management Care
NCT06807580 · Transgender Women
NCT07187947 · Gender Incongruence, Cardiovascular (CV) Risk, and more
NCT06177600 · Transgender Persons, Health Services for Transgender Persons, and more
Peking University Third Hospital
Beijing, Beijing Municipality
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions